Altman Advisors, Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 1731671 CHICAGO, IL

Position in GILD

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$2,770,762

-$294,263 QoQ

Shares Held

21,931

-0.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

1.22%

of 13F equity value

Holder Rank

#733

of 2,266 holders

Holding Since

Mar 2020

18 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Altman Advisors, Inc. holds $13,882,576 across 5 Drug Manufacturers - General names. GILD ranks #2 (20.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,236	$3,881,355
2	GILD	Gilead Sciences, Inc. This page	21,931	$2,770,762
3	ABBV	AbbVie Inc.	9,733	$2,449,212
4	JNJ	Johnson & Johnson	9,634	$2,446,746
5	NVS	Novartis AG	14,896	$2,334,501

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,770,762	21,931	-0.3%	Shares	Sole	2026-08-11
2026-03-31	$3,065,025	21,992	-2.3%	Shares	Sole	2026-05-05
2025-12-31	$2,762,263	22,505	+0.8%	Shares	Sole	2026-02-04
2025-09-30	$2,477,409	22,319	+1.5%	Shares	Sole	2025-11-13
2025-06-30	$2,437,587	21,986	+3.4%	Shares	Sole	2025-08-07
2025-03-31	$2,383,303	21,270	+1.5%	Shares	Sole	2025-05-02
2024-12-31	$1,935,428	20,953	+0.4%	Shares	Sole	2025-02-13
2024-09-30	$1,750,160	20,875	+1.2%	Shares	Sole	2024-11-08
2024-06-30	$1,414,875	20,622	+2.8%	Shares	Sole	2024-08-08
2024-03-31	$1,469,981	20,068	+4.6%	Shares	Sole	2024-05-09
2023-12-31	$1,554,662	19,191	-0.7%	Shares	Sole	2024-02-08
2023-09-30	$1,448,065	19,323	+0.9%	Shares	Sole	2023-11-14
2023-03-31	$1,588,460	19,145	+1.9%	Shares	Sole	2023-05-09
2022-12-31	$1,612,348	18,781	-3.4%	Shares	Sole	2023-02-08
2022-09-30	$1,199,191	19,439	+221.1%	Shares	Sole	2022-11-08
2020-09-30	$382,552	6,054	-80.3%	Shares	Sole	2020-11-13
2020-06-30	$2,367,982	30,777	-0.2%	Shares	Sole	2020-08-12
2020-03-31	$2,306,495	30,852	—	Shares	Sole	2020-04-20
No filing history on record for this holder in this stock.